Leukemia/lymphoma-associated gene fusions in normal individuals

被引:14
作者
Brassesco, M. S. [1 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pediat & Puericultura, Ribeirao Preto, SP, Brazil
关键词
Gene fusions; Genomic instability; Leukemia; Lymphoma; Healthy individuals;
D O I
10.4238/vol7-3gmr486
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoietic neoplasias are characterized by recurrent chromosomal aberrations that result in the formation of gene fusions and the subsequent expression of chimeric proteins with unique properties. However, in recent years, different lymphoma/leukemia-associated rearrangements, such as BCR/ABL, IGH/BCL2, ETV6/RUNX1 and MLL duplications, have been detected in healthy individuals. The presence of these rearrangements indicates that such translocations can be generated in normal hematopoietic cells without apparent oncogenic consequences. This article reviews and discusses the data available in the literature.
引用
收藏
页码:782 / 790
页数:9
相关论文
共 80 条
[1]  
Alexander FE, 2001, CANCER RES, V61, P2542
[2]   The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo [J].
Andreasson, P ;
Schwaller, J ;
Anastasiadou, E ;
Aster, J ;
Gilliland, DG .
CANCER GENETICS AND CYTOGENETICS, 2001, 130 (02) :93-104
[3]   Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults [J].
Baesecke, Joerg ;
Podleschny, Martina ;
Clemens, Robert ;
Schnittger, Susanne ;
Viereck, Volker ;
Truemper, Lorenz ;
Griesinger, Frank .
LEUKEMIA RESEARCH, 2006, 30 (09) :1091-1096
[4]   Leukemia- and lymphoma-associated genetic aberrations in healthy individuals [J].
Bäsecke, J ;
Griesinger, F ;
Trümper, L ;
Brittinger, G .
ANNALS OF HEMATOLOGY, 2002, 81 (02) :64-75
[5]   OCCURRENCE OF BCL-2 ONCOGENE TRANSLOCATION WITH INCREASED FREQUENCY IN THE PERIPHERAL-BLOOD OF HEAVY SMOKERS [J].
BELL, DA ;
LIU, YF ;
CORTOPASSI, GA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :223-224
[6]  
Betti CJ, 2003, CANCER RES, V63, P1377
[7]  
BIERNAUX C, 1995, BLOOD, V86, P3118
[8]   Specific human cellular immunity to bcr-abl oncogene-derived peptides [J].
Bocchia, M ;
Korontsvit, T ;
Xu, Q ;
Mackinnon, S ;
Yang, SY ;
Sette, A ;
Scheinberg, DA .
BLOOD, 1996, 87 (09) :3587-3592
[9]   The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease [J].
Bose, S ;
Deininger, M ;
Gora-Tybor, J ;
Goldman, JM ;
Melo, JV .
BLOOD, 1998, 92 (09) :3362-3367
[10]   Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients [J].
Brassesco, MS ;
Camparoto, ML ;
Tone, LG ;
Sakamoto-Hojo, ET .
CYTOGENETIC AND GENOME RESEARCH, 2004, 104 (1-4) :346-351